Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
Lipovaxin-MM 是一种新型的靶向树突状细胞的脂质体疫苗，用于治疗恶性黑色素瘤，目前正在进行 I 期临床试验。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-018-2207-z
Gargett, Tessa; Abbas, M Nazim; Rolan, Paul; Price, Jason D; Gosling, Katharine M; Ferrante, Antonio; Ruszkiewicz, Andrew; Atmosukarto, Ines I C; Altin, Joseph; Parish, Christopher R; Brown, Michael P
树突状细胞
多发性骨髓瘤
免疫/内分泌
黑色素瘤
细胞生物学
树突状细胞
